These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33442092)

  • 1. Health-Related Quality of Life (HRQoL) of Adult Filipinos with Graves' Disease cured by Radioiodine Therapy compared to those controlled by Antithyroid Drugs at University of Santo Tomas Hospital: A Pilot Study.
    Mangelen SF; Cunanan E
    J ASEAN Fed Endocr Soc; 2017; 32(2):100-107. PubMed ID: 33442092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
    Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
    Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
    Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
    Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease.
    Donovan PJ; McLeod DS; Little R; Gordon L
    Eur J Endocrinol; 2016 Dec; 175(6):595-603. PubMed ID: 27634939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves' Disease in Ethiopia.
    Mengistu HS; Getahun KT; Alemayehu L; Gezahign S
    Clinicoecon Outcomes Res; 2022; 14():221-229. PubMed ID: 35431562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves' disease.
    Li Y; Yang T; Ju L; Feng Y; Chen Z; Xiang X; Zhu T; Pang H; Wang Z
    Clin Endocrinol (Oxf); 2024 Jan; 100(1):87-95. PubMed ID: 37964632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between the Treatment Modalities for Graves' Disease at King Abdulaziz Medical City, Jeddah.
    Zarif HA; Alam SS; Baashar A; Alsharif A; Alhilabi M
    Cureus; 2020 Jan; 12(1):e6730. PubMed ID: 32015936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment choice, satisfaction and quality of life in patients with Graves' disease.
    Conaglen HM; Tamatea JAU; Conaglen JV; Elston MS
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):977-984. PubMed ID: 29633307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of prior antithyroid drug use on delaying remission in high uptake Graves' disease following radioiodine ablation.
    Subramanian M; Baby MK; Seshadri KG
    Endocr Connect; 2016 Jan; 5(1):34-40. PubMed ID: 26772754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
    Acharya SH; Avenell A; Philip S; Burr J; Bevan JS; Abraham P
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):943-50. PubMed ID: 18429949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
    Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
    S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
    Côté-Bigras S; Tran V; Turcotte S; Rola-Pleszczynski M; Verreault J; Rottembourg D
    Endocrine; 2016 Jun; 52(3):587-96. PubMed ID: 26701678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
    Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
    Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired health-related quality of life in Graves' disease. A prospective study.
    Elberling TV; Rasmussen AK; Feldt-Rasmussen U; Hørding M; Perrild H; Waldemar G
    Eur J Endocrinol; 2004 Nov; 151(5):549-55. PubMed ID: 15538931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.